BTAI - BioXcel Therapeutics to Report Third Quarter 2023 Financial Results on November 14 2023 | Benzinga
NEW HAVEN, Conn., Oct. 31, 2023 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will release its third quarter 2023 financial results on Tuesday, November 14, 2023 before the open of the U.S. financial markets. BioXcel Therapeutics' management team will also host a conference call and webcast at 8:00 AM ET that day to discuss the Company's financial results and to provide a general business update.
| Conference Call & Webcast Details |
| Date/Time: |
| Tuesday, November 14, 2023, at 8:00 AM Eastern Time |
| Domestic: |
| 877-407-5795 |
| International: |
| 201-689-8722 |
The webcast link will be accessible under "News/Events" on the Investors & Media page of the Company's website at www.bioxceltherapeutics.com.
| Replay* |
| Domestic: |
| 877-660-6853 |
| International: |
| 201-612-7415 |
| Conference ID: |
| 13742187 |
*Replay available through February 14, 2024
About BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. (NASDAQ: